Physician profile
Nova Szoka
NPI 1912227083
$5,775.10
in general payments reported to CMS, 2019-2025
8 companies · $2,806 in 2025
The $2,806 reported for 2025 was more than what 76% of Obesity Medicine (Internal Medicine) providers received nationally (typical 2025 total: $202).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2022: $209 · 2023: $444 · 2024: $2,001 · 2025: $2,806.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,698 · Food and Beverage: $1,103 · Consulting Fee: $400 · Entertainment: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,698.14 |
| Food and Beverage | $1,102.95 |
| Consulting Fee | $400.00 |
| Entertainment | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endolumik, INC. | $4,333.64 | 2024-2025 | Endolumik Gastric Calibration Tube, Endolumik Gastric Calibration Tube |
| Ethicon INC. | $715.19 | 2019-2025 | |
| Intuitive Surgical, INC. | $231.35 | 2022-2023 | Da Vinci Surgical System |
| Davol INC. | $155.03 | 2023 | Phasix Mesh |
| Reshape Lifesciences INC. | $121.38 | 2023 | |
| Medtronic, INC. | $104.04 | 2023 | Endo Gia Ultra |
| Ethicon US, LLC | $72.99 | 2024 | Surgiflo Hemostatic Matrix, Surgicel Nu-Knit, Vistaseal |
| Baxter Healthcare | $41.48 | 2023 | Seprafilm, Tisseel, Peri-Strips Dry |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,604,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nova Szoka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.